Tradestie Institutional Equity Comparison Engine
CDIOW vs OABIW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OABIW Overall Edge
OABIW Captures Institutional Edge (1โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OABIW (OABIW) driven by superior Momentum & Technical. Fundamentally, CDIOW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus OABIW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CDIOW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OABIW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CDIOW N/M vs OABIW N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
OABIW
1Y -58.7% vs +43.9% ยท 52W Pos 1% vs 63%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CDIOW
NASDAQ
Cardio Diagnostics Holdings Inc. Warrant
In Vitro & In Vivo Diagnostic Substances
$0.01
-38.54% 1D
Market Cap
N/A
1M Return
-41.0%
1Y Return
-58.74%
Forward P/E
N/M
Unified AI Score
35.2 / 100
SELL
Tech 15.0
Fund 33.0
Flow 50.0
Mom 40.0
OABIW
US Equity
OABIW
Institutional Equity
$0.41
-2.38% 1D
Market Cap
N/A
1M Return
+44.11%
1Y Return
+43.86%
Forward P/E
N/M
Unified AI Score
49.4 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CDIOW -58.74%
OABIW +43.86%
Spread: +159.25 pp (OABIW Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CDIOW TTM Op. Margin: N/A
OABIW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDIOW vs OABIW. Trailing 12-month operating profitability (CDIOW N/A vs OABIW N/A) and valuation multiples (CDIOW N/M vs OABIW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CDIOW | OABIW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 1% ($0โ$0) | 63% ($0โ$1) | Stronger Trend | OABIW |
| Beta / 30D Volatility Risk Regime | 1.59ฮฒ ยท 280% Vol | -4.10ฮฒ ยท 376% Vol | Lower Realized Risk | CDIOW |
| Unified Institutional Score Composite Signal | 35.2 / 100 (SELL) | 49.4 / 100 (HOLD) | Higher Composite | OABIW |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CDIOW vs OABIW Buy Guide
CDIOW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
OABIW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CDIOW nor OABIW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.